Prediction of the risk of myocardial infarction from polymorphisms in candidate genes.
By Yoshiji Yamada, H. Izawa, S. Ichihara, F. Takatsu, H. Ishihara, H. Hirayama, T. Sone, Masashi Tanaka, M. Yokota. New England Journal of Medicine, 2002
710 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/ae8c3f350e270549bfd3acf8041ac3c29dd4ceb1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Peter Libby
- G. Hansson
- S. Grundy
- P. Ridker
- J. Willerson
- G. Assmann
- Francis G. Spinale
- Douglas P. Zipes
In Molecular Biology
- Peter Libby
- P. Ridker
- G. Hansson
- Yusuke Nakamura
- Eric Boerwinkle
- Francis G. Spinale
- S. Grundy
- Douglas P. Zipes
Citations in the corpus
- The Family of Connexin Genes (2009, neutral): “In other studies, the GJA4-T1019 SNP is a risk factor for acute myocardial infarction among Japanese [96,97] and Sicilian males [98].”
- Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction (2006, background): “…to MI have been indicated to be present on several chromosomal loci through linkage analyses or case-control association studies using single nucleotide polymorphism (SNP) (Topol et al. 2001; Yamada et al. 2002; Ozaki et al. 2002, 2004, 2006; Stenina et al. 2003; Helgadottir et al. 2004).”
- Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. (2007, background): “In a study performed in over 2,800 Japanese patients, the 5A polymorphism was associated with increased risk of MI in women (514).”
- From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003, background): “A recent study suggested an association between several genetic polymorphisms and clinical outcomes, some of which can be possibly related to plaque, blood, and myocardial vulnerability [104].”
- From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (2003, background): “A recent study suggested an association between several genetic polymorphisms and clinical outcomes, some of which can be possibly related to plaque, blood, and myocardial vulnerability [104].”